SHORE-C
Wheelwright, S., Maunsell, R., Taylor, S., Drinkwater, N., Erridge, C., Foster, C., ... & White, S. (2023). Development of 'gastrostomy tube - is it for me?', a web-based patient decision aid for people living with motor neurone disease considering having a gastrostomy tube placed. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 1-9. www.tandfonline.com/doi/full/10.1080/21678421.2023.2220743 Published 19/07/2023
Fallowfield, L., Starkings, R., Palmieri, C., Tait, A., Stephen, L., May, S., ... & Jenkins, V. (2023). Living with metastatic breast cancer (LIMBER): experiences, quality of life, gaps in information, care and support of patients in the UK. Supportive Care in Cancer, 31(8), 459. https://doi.org/10.1007/s00520-023-07928-8 Published 11/07/2023
Menon, U., Gentry-Maharaj, A., Burnell, M., Ryan, A., Kalsi, J. K., Singh, N., ... & Jacobs, I. J. (2023). Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial. Health Technology Assessment, 11, 1-81. https://doi.org/10.3310/BHBR5832 Published 31/05/2023
Fallowfield L J, Solis-Trapala I, Starkings R, May S, Matthews L, Eccles D, Evans G, Turnbull C, Crawford G, Jenkins V Talking about Risk, UncertaintieS of Testing IN Genetics (TRUSTING): development and evaluation of an educational programme for healthcare professionals about BRCA1 & BRCA2 testing , British Journal of Cancer, Published 17 June 2022 https://doi.org/10.1038/s41416-022-01871-x Published 17/06/2022
Di Maio M, Basch E, Denis F, Fallowfield L J, Ganz P A, Howell D, Kowalski D, Perrone F, Stover A M, Sundaresan P, Warrington L, Zhang L, Apostolidis K, Freeman-Daily J, Ripamonti C I, Santini D, on behalf of the ESMO Guidelines Committee The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline, Annals of Oncology, Published 21/04/2022
Glasspool, R., Wheelwright, S., Bolton, V., Calman, L., Cummings, A., Elledge, B., ... & Foster, C. (2022). Modifiable pre-treatment factors are associated with quality of life in women with gynaecological cancers at diagnosis and one year later: Results from the HORIZONS UK national cohort study. Gynecologic Oncology, 165(3), 610-618. https://doi.org/10.1016/j.ygyno.2022.03.012 Published 26/03/2022
Fallowfield, L. J., Farewell, D., Jones, H., May, S., Catt, S., Starkings, R., & Jenkins, V. (2022). IMPARTER, Phase 1 of an intervention to improve patients' understanding of gene expression profiling tests in breast cancer. Breast Cancer Research and Treatment, 1-7. https://doi.org/10.1007/s10549-021-06491-2 Published 04/01/2022
Torr B, Jones C, Choi S, Allen S, Kavanaugh G, Hamill M, Garrett A, MacMahon S, Loong L, Reay A, Yuan L, Petrizan M V, Monson K, Perry N, Fallowfield L, Jenkins V, Gold R, Taylor A, Gabe R, Wiggins J, Lucassen A, Manchanda R, Gandhi A, George A, Hubank M, Kemp Z, Evans G, Bremner S, Turnbull C A digital pathway for genetic testing in UK NHS patients with cancer: BRCA-DIRECT randomised study internal pilot, http://dx.doi.org/10.1136/jmg-2022-108655. Journal of Medical Genetics, Published 22 July 2022
Read more about SHORE-C here >